DK1945647T3 - Fremgangsmåder til fremstilling af maytansinol - Google Patents

Fremgangsmåder til fremstilling af maytansinol

Info

Publication number
DK1945647T3
DK1945647T3 DK06844315.9T DK06844315T DK1945647T3 DK 1945647 T3 DK1945647 T3 DK 1945647T3 DK 06844315 T DK06844315 T DK 06844315T DK 1945647 T3 DK1945647 T3 DK 1945647T3
Authority
DK
Denmark
Prior art keywords
maytansinol
methods
bridged
preparing maytansinol
preparing
Prior art date
Application number
DK06844315.9T
Other languages
English (en)
Inventor
Ravi V J Chari
Wayne C Widdison
Original Assignee
Immunogen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunogen Inc filed Critical Immunogen Inc
Application granted granted Critical
Publication of DK1945647T3 publication Critical patent/DK1945647T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK06844315.9T 2005-11-08 2006-11-08 Fremgangsmåder til fremstilling af maytansinol DK1945647T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US73433005P 2005-11-08 2005-11-08
PCT/US2006/043718 WO2007056550A2 (en) 2005-11-08 2006-11-08 Processes for preparation of maytansinol

Publications (1)

Publication Number Publication Date
DK1945647T3 true DK1945647T3 (da) 2012-05-07

Family

ID=38024003

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06844315.9T DK1945647T3 (da) 2005-11-08 2006-11-08 Fremgangsmåder til fremstilling af maytansinol

Country Status (10)

Country Link
US (1) US7411063B2 (da)
EP (1) EP1945647B9 (da)
JP (1) JP5117390B2 (da)
AT (1) ATE540956T1 (da)
AU (1) AU2006311485B2 (da)
CA (1) CA2625867C (da)
DK (1) DK1945647T3 (da)
ES (1) ES2380687T3 (da)
PL (1) PL1945647T3 (da)
WO (1) WO2007056550A2 (da)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100056762A1 (en) 2001-05-11 2010-03-04 Old Lloyd J Specific binding proteins and uses thereof
US7589180B2 (en) 2001-05-11 2009-09-15 Abbott Laboratories Inc. Specific binding proteins and uses thereof
US9090693B2 (en) 2007-01-25 2015-07-28 Dana-Farber Cancer Institute Use of anti-EGFR antibodies in treatment of EGFR mutant mediated disease
JP5618549B2 (ja) 2007-03-15 2014-11-05 ルードヴィッヒ インスティテュート フォー キャンサーリサーチ リミテッド Ｅｇｆｒ抗体及びｓｒｃ阻害剤を用いる治療方法及び関連製剤
JP5532486B2 (ja) 2007-08-14 2014-06-25 ルードヴィッヒ インスティテュート フォー キャンサー リサーチ Ｅｇｆ受容体を標的とするモノクローナル抗体１７５ならびにその誘導体および用途
FR2949469A1 (fr) * 2009-08-25 2011-03-04 Sanofi Aventis Derives anticancereux, leur preparation et leur application en therapeutique
ES2544608T3 (es) 2010-11-17 2015-09-02 Genentech, Inc. Conjugados de anticuerpo y de alaninil-maitansinol
AU2012395148B2 (en) 2012-11-24 2016-10-27 Hangzhou Dac Biotech Co., Ltd. Hydrophilic linkers and their uses for conjugation of drugs to cell binding molecules
US10208125B2 (en) 2013-07-15 2019-02-19 University of Pittsburgh—of the Commonwealth System of Higher Education Anti-mucin 1 binding agents and uses thereof
TWI541022B (zh) 2013-12-18 2016-07-11 應克隆公司 針對纖維母細胞生長因子受體－３（ｆｇｆｒ３）之化合物及治療方法
ES2960619T3 (es) 2014-02-28 2024-03-05 Hangzhou Dac Biotech Co Ltd Enlazadores cargados y sus usos para la conjugación
TW201711702A (zh) 2015-06-04 2017-04-01 應克隆公司 使用針對纖維母細胞生長因子受體３（ｆｇｆｒ３）之化合物的療法
NZ739830A (en) 2015-07-12 2021-12-24 Hangzhou Dac Biotech Co Ltd Bridge linkers for conjugation of cell-binding molecules
US9839687B2 (en) 2015-07-15 2017-12-12 Suzhou M-Conj Biotech Co., Ltd. Acetylenedicarboxyl linkers and their uses in specific conjugation of a cell-binding molecule
US20210308277A1 (en) 2016-11-14 2021-10-07 Hangzhou Dac Biotech Co., Ltd. Conjugation linkers, cell binding molecule-drug conjugates containing the linkers, methods of making and uses such conjugates with the linkers
EP4219509A1 (en) 2019-03-01 2023-08-02 Celgene Corporation Preparation of maytansinol
PT3956332T (pt) 2019-04-18 2023-04-24 Indena Spa Processo diasterosselectivo para a preparação de ésteres de maitansinoides contendo tiol ou dissulfeto e seus intermediários
MX2022000450A (es) 2019-07-10 2022-04-25 Cybrexa 3 Inc Conjugados peptídicos de agentes dirigidos a microtúbulos como terapéuticos.
EP3997093A1 (en) 2019-07-10 2022-05-18 Cybrexa 2, Inc. Peptide conjugates of cytotoxins as therapeutics
JPWO2021107133A1 (da) 2019-11-29 2021-06-03

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5566586A (en) * 1978-11-14 1980-05-20 Takeda Chem Ind Ltd Novel maytansinoid compound and its preparation
US6333410B1 (en) * 2000-08-18 2001-12-25 Immunogen, Inc. Process for the preparation and purification of thiol-containing maytansinoids
JP2005525423A (ja) * 2002-05-13 2005-08-25 スミスクライン・ビーチャム・コーポレイション メイタンシノールの調製方法

Also Published As

Publication number Publication date
JP2009514978A (ja) 2009-04-09
JP5117390B2 (ja) 2013-01-16
EP1945647B9 (en) 2012-11-14
EP1945647A2 (en) 2008-07-23
US7411063B2 (en) 2008-08-12
US20070112188A1 (en) 2007-05-17
ATE540956T1 (de) 2012-01-15
ES2380687T3 (es) 2012-05-17
AU2006311485B2 (en) 2012-09-27
CA2625867C (en) 2014-12-23
PL1945647T3 (pl) 2012-04-30
EP1945647B1 (en) 2012-01-11
CA2625867A1 (en) 2007-05-18
WO2007056550A2 (en) 2007-05-18
AU2006311485A1 (en) 2007-05-18
WO2007056550A3 (en) 2007-12-06
EP1945647A4 (en) 2010-10-20

Similar Documents

Publication Publication Date Title
DK1945647T3 (da) Fremgangsmåder til fremstilling af maytansinol
DK1633697T3 (da) Fremgangsmåde til fremstilling af substituerede 3-aryl-butyl-aminforbindelser
ATE427965T1 (de) Antikírper gegen 25-hydroxyvitamin d
ECSP056111A (es) Derivados de 2-acilamino-4-feniltiazol, su preparación y aplicación en terapeutica
EA200702550A1 (ru) Способ получения эпоксида
EA200801560A1 (ru) Бифенилкарбоксамиды
TW200942525A (en) Process for producing epichlorohydrin
CR7728A (es) Nuevas quinazolinas espirocondensadas y su uso como inhibidores de la fosfodiesterasa
NO20066078L (no) Metode for fremstilling av Entecavir og nye mellomprodukter derav via karbon-silisium oksidasjon
SE0300924D0 (sv) A method to provide a triple well in an epitaxially based CMOS or BiCMOS process
ATE483311T1 (de) Prozesskonfiguration in einem netzwerk
WO2005073152A3 (de) Verfahren zur herstellung von polyisobutenylphenolen
DK2089371T3 (da) Fremstillingsmåde til fremstilling af hexahydrofuro[2,3-b]furan-3-OL
EA200602169A1 (ru) Способ получения производных 2-оксо-1-пирролидина внутримолекулярным аллилированием
TW200619205A (en) A method for preparing irbesartan and intermediates thereof
SG170081A1 (en) Method of patterning and product(s) obtained therefrom
EA200600485A1 (ru) Способ получения производных 2-оксо-1-пирролидина
HRP20051005A2 (en) Process for the preparation of nonpeptide substituted spirobenzoazepine derivatives
EA200801573A1 (ru) Способ получения кристаллических форм орлистата
DK1410382T3 (da) Fremgangsmåde til støjreduktion i et høreapparat til implementering af en sådan fremgangsmåde
AP2277A (en) Process for production of 1,2,2,2-tertafluoro ethyl difluoro methyl ether.
EA201001872A1 (ru) Новые способы получения производных циклопропиламида
EA200801404A1 (ru) Новый способ получения 5-амино-3н-тиазоло[4,5-d]пиримидин-2-она
ATE489368T1 (de) Pyrimidinonverbindungen als calcilytica
EA200801239A1 (ru) Новые способы получения пиперазинильных и диазепанильных производных бензамина